Atlas Trials

Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma

Clinical trial NCT01492881 · WITHDRAWN

Trial details

NCT number
NCT01492881
Sponsor
UNC Lineberger Comprehensive Cancer Center
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2012-04-01
Primary completion
2015-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.